Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Choroidal Subretinal Neovascularization With Agents Directed Against the Immune Response

NCT00304954 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00304954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00304954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Choroidal Subretinal Neovascularization With Agents Directed Against the Immune Response
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
January 31, 2010
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, choroidal neovascularization